Dr Scher on the Importance of Molecular Testing in Prostate Cancer

Howard I. Scher, MD, discusses the evolution of molecular testing mechanisms in patients with prostate cancer and highlights the importance of making patient-centered decisions based on test results.

Related Keywords

D Wayne Calloway ,Howardi Scher , ,Biomarker Development Program ,Memorial Sloan Kettering Cancer Center ,Calloway Chair ,Urologic Oncology ,D ,Patients With Prostate Cancer ,